Moreover, benign prostate hypertrophy (BPH) (n = 20) and prostate cancer (PC) (n = 64) tissue samples were analysed to study the correlation of ADAM10 localization with clinical parameters such as Gleason score and preoperative prostate-specific-antigen (PSA) levels. This evidence concerns the gene ADAM10 and Familial prostate cancer.